Delivery Order SPE2DB22D1041-SPE2DB25FUBU6
Award Date 9/5/25
Potential Completion Date 9/8/25
Potential Value $42K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $41,531.33 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Menquadfi vials (0.5mL). The contract is firm fixed price with no set-aside designation and an ultimate completion date of September 8, 2025. AmerisourceBergen will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Menquadfi vial 0.5ml pharmaceutical products. This firm fixed-price delivery order, valued at $5,085.08, is due for completion by September 19, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award was made on a competitive basis without set-aside provisions, reflecting AmerisourceBergen's demonstrated capability to meet federal...
- The Defense Logistics Agency awarded a delivery order valued at $18,365.68 to AmerisourceBergen Drug Corp for the supply of Menquadfi vials (0.5ML) on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $2,179.32 to AmerisourceBergen Drug Corp for the supply of Menquadfi vials (0.5mL) to support federal medical procurement needs. This non-competitive delivery order, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a firm fixed-price transaction under a larger contract vehicle. The work will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,579.17 to AmerisourceBergen Drug Corp for Menquadfi Vial 0.5ML on December 4, 2025, with an ultimate completion date of December 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $45,907.20 to AmerisourceBergen Drug Corp for the supply of Menquadfi vials (0.5ML) on September 25, 2025, with an ultimate completion date of September 26, 2025. This competitively awarded, firm fixed-price contract requires performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. No set-aside provisions were utilized in this award. This delivery order operates under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $29,333.15 to AmerisourceBergen Drug Corp for Menquadfi vial 0.5ML on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively bid with no set-aside designation and will...
- The Defense Logistics Agency awarded a delivery order valued at $21,401.45 to AmerisourceBergen Drug Corp for the supply of Menquadfi vials (0.5ML) on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,905.80 to AmerisourceBergen Drug Corp for MENQUADFI vial 0.5ML on September 11, 2025, with completion targeted for September 12, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $15,267.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Menquadfi vials (0.5 mL) under contract number 4568509212. This is a non-set-aside award issued on June 10, 2025, with an ultimate completion date of June 11, 2025. The vials will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary operations. This delivery order represents a discrete task...